VVOS — Vivos Therapeutics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2020-12-11.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-03-31 | Skaff Michael C 10% owner | Open-market purchase | 1.0M | 1.34 | 1.4M |
| 2026-03-31 | V-Co Investors 3 LLC 10% owner | Open-market purchase | 1.0M | 1.34 | 1.4M |
| 2026-03-31 | Skaff Michael C 10% owner | Open-market purchase | 308.8K | 1.34 | 413.9K |
| 2026-03-31 | V-Co Investors 3 LLC 10% owner | Open-market purchase | 308.8K | 1.34 | 413.9K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| ARMISTICE CAPITAL, LLC | 1.3M | 1.1M |
| GEODE CAPITAL MANAGEMENT, LLC | 112.7K | 95.5K |
| COMMONWEALTH EQUITY SERVICES, LLC | 50.1K | 42.5K |
| IHT Wealth Management, LLC | 48.5K | 41.1K |
| Centurion Wealth Management LLC | 42.1K | 35.7K |
| B. Riley Wealth Advisors, Inc. | 41.5K | 38.1K |
| VANGUARD FIDUCIARY TRUST CO | 36.4K | 30.8K |
| BlackRock, Inc. | 32.8K | 27.8K |
| XTX Topco Ltd | 29.6K | 25.1K |
| STATE STREET CORP | 29.4K | 24.9K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-14 | — | on EDGAR ↗ |
| 8-K | 2026-08-11 | 2026-08-05 | on EDGAR ↗ |
| SCHEDULE 13G | 2026-08-11 | — | on EDGAR ↗ |
| 8-K | 2026-08-03 | 2026-07-31 | on EDGAR ↗ |
| SCHEDULE 13D | 2026-07-15 | — | on EDGAR ↗ |
| 4 | 2026-07-15 | 2026-06-30 | on EDGAR ↗ |
| 3 | 2026-07-15 | 2026-06-30 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Vivos Therapeutics, Inc. (VVOS) filed form 8-K · 2026-08-21 · SEC EDGAR
- Vivos Therapeutics GAAP EPS of -$0.31 misses by $0.01, revenue of $5.15M misses by $0.99M · 2026-08-17
- Vivos Therapeutics, Inc. (VVOS) filed form 10-Q · 2026-08-14 · SEC EDGAR
- Vivos Therapeutics, Inc. (VVOS) filed form SCHEDULE 13G/A · 2026-08-14 · SEC EDGAR
- Vivos Therapeutics, Inc. (VVOS) filed form 8-K · 2026-08-11 · SEC EDGAR
Ask the AI about VVOS
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →